The Epoch Times
The Epoch Times
Focus

Vaxzevria

UK News
UK News
|
Patricia Devlin

Tough Tax Led to Britain Losing £320 million Vaccine Factory: Pharma Chief

Feb 10, 2023
|
Patricia Devlin
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Tough Tax Led to Britain Losing £320 million Vaccine Factory: Pharma Chief
Feb 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Europe
Europe
|
Reuters

AstraZeneca Finds Small Clot Risk After 1st COVID Shot, Less After 2nd

Jul 28, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
AstraZeneca Finds Small Clot Risk After 1st COVID Shot, Less After 2nd
Jul 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Europe
Europe
|
Reuters

EU Adds Another Rare Blood Condition as Side Effect of AstraZeneca Shot

Jun 11, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
EU Adds Another Rare Blood Condition as Side Effect of AstraZeneca Shot
Jun 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
Patricia Devlin

Tough Tax Led to Britain Losing £320 million Vaccine Factory: Pharma Chief

Feb 10, 2023
|
Patricia Devlin
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Tough Tax Led to Britain Losing £320 million Vaccine Factory: Pharma Chief
Feb 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Europe
Europe
|
Reuters

AstraZeneca Finds Small Clot Risk After 1st COVID Shot, Less After 2nd

Jul 28, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
AstraZeneca Finds Small Clot Risk After 1st COVID Shot, Less After 2nd
Jul 28
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Europe
Europe
|
Reuters

EU Adds Another Rare Blood Condition as Side Effect of AstraZeneca Shot

Jun 11, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
EU Adds Another Rare Blood Condition as Side Effect of AstraZeneca Shot
Jun 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.